ABHD antagonist 1
ABHD antagonist 1 possesses ABHD6 (α/β-Hydrolase domain containing 6) inhibitory activity, involving the regulation of biochemical pathways involved in ABHD6, thereby affecting cell function and inflammatory response. ABHD antagonist 1 can be used in pain, neuropathic diseases, inflammatory diseases. Autoimmune diseases, metabolic diseases, and cancer research[1].
Product Specifications
CAS Number
[3034510-10-3]
UNSPSC
12352005
Target
MAGL
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology; Neurological Disease; Others
Assay Protocol
https://www.medchemexpress.com/abhd-antagonist-1.html
Smiles
O=C(N1C[C@@]2([H])[C@@]([C@H](OC3=NN=C(Br)C=C3)CC2)([H])C1)C(S4)=CC5=C4CCOC5
Molecular Formula
C19H20BrN3O3S
Molecular Weight
450.35
References & Citations
[1] , et al. Abhd6 antagonist.WO2024071398A1.2023-09-29
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human DSCAML1 shRNA (UAS) - Lentiviral human DSCAML1 shRNA (UAS, RFP) (25)